Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ascendis Pharma A (ASND) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Ascendis Pharma A (ASND) over the last 14 years, with Q4 2025 value amounting to 0.12.

  • Ascendis Pharma A's Equity Ratio fell 3947.8% to 0.12 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.12, marking a year-over-year decrease of 3947.8%. This contributed to the annual value of 0.12 for FY2025, which is 3947.8% down from last year.
  • As of Q4 2025, Ascendis Pharma A's Equity Ratio stood at 0.12, which was down 3947.8% from 0.09 recorded in Q4 2024.
  • Ascendis Pharma A's 5-year Equity Ratio high stood at 0.83 for Q1 2021, and its period low was 0.18 during Q4 2023.
  • Over the past 5 years, Ascendis Pharma A's median Equity Ratio value was 0.44 (recorded in 2021), while the average stood at 0.37.
  • In the last 5 years, Ascendis Pharma A's Equity Ratio plummeted by 17302.64% in 2023 and then soared by 4921.73% in 2024.
  • Over the past 5 years, Ascendis Pharma A's Equity Ratio (Quarter) stood at 0.44 in 2021, then crashed by 45.36% to 0.24 in 2022, then crashed by 173.03% to 0.18 in 2023, then soared by 49.22% to 0.09 in 2024, then crashed by 39.48% to 0.12 in 2025.
  • Its Equity Ratio was 0.12 in Q4 2025, compared to 0.09 in Q4 2024 and 0.18 in Q4 2023.